Search by Drug Name or NDC
NDC 70436-0041-01 Guanfacine 3 mg/1 Details
Guanfacine 3 mg/1
Guanfacine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC. The primary component is GUANFACINE HYDROCHLORIDE.
Product Information
| NDC | 70436-0041 |
|---|---|
| Product ID | 70436-041_0c604d5f-31b0-7c5b-e063-6294a90a6072 |
| Associated GPIs | |
| GCN Sequence Number | 065573 |
| GCN Sequence Number Description | guanfacine HCl TAB ER 24H 3 MG ORAL |
| HIC3 | H8M |
| HIC3 Description | TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST |
| GCN | 27579 |
| HICL Sequence Number | 000120 |
| HICL Sequence Number Description | GUANFACINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Guanfacine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | guanfacine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUANFACINE HYDROCHLORIDE |
| Labeler Name | Slate Run Pharmaceuticals, LLC |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213428 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70436-0041-01 (70436004101)
| NDC Package Code | 70436-041-01 |
|---|---|
| Billing NDC | 70436004101 |
| Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-041-01) |
| Marketing Start Date | 2022-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.22598 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | GUANFACINE HCL ER 3 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis